Xanthoceraside hollow gold nanoparticles, green pharmaceutics preparation for poorly water-soluble natural anti-AD medicine

International Journal of Pharmaceutics

Volumn 506, Issue 1-2, 2016, Pages 184-190

  Meng, Da Li ^a   Shang, Lei ^b   Feng, Xiao He ^a   Huang, Xing Fei ^a   Che, Xin ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Green pharmaceutics preparation; Hollow gold nanoparticles; Natural anti AD medicine; Xanthoceraside

Indexed keywords

ANTIDIABETIC AGENT; GOLD NANOPARTICLE; NATURAL PRODUCT; SILICON DIOXIDE; SOLVENT; UNCLASSIFIED DRUG; XANTHOCERASIDE; DRUG; DRUG CARRIER; GOLD; METAL NANOPARTICLE; SAPONIN; TRITERPENE; WATER;

AGED; ALZHEIMER DISEASE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DNA TEMPLATE; DRUG SOLUBILITY; HUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; CHEMISTRY; PHARMACEUTICS; PROCEDURES; SOLUBILITY;

ALZHEIMER DISEASE; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG CARRIERS; GOLD; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; PHARMACEUTICAL PREPARATIONS; SAPONINS; SILICON DIOXIDE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TRITERPENES; WATER; X-RAY DIFFRACTION;

EID: 84964522765     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2016.04.042     Document Type: Article

References (40)

1. S.N. Abdollahi, M. Naderi, and G. Amoabediny Synthesis and characterization of hollow gold nanoparticles using silica spheres as templates Colloid Surf. A 436 2013 1069 1075
2. M.B. Bindu, B. Kusum, and D. Banji Novel strategies for poorly water soluble drugs Int. J. Pharm. Sci. Rev. Res. 4 2010 76 84
3. K. Burapapadh, H. Takeuchi, and P. Sriamornsak Novel pectin-based nanoparticles prepared from nanoemulsion templates for improving in vitro dissolution and in vivo absorption of poorly water-soluble drug Eur. J. Pharm. Biopharm. 82 2012 250 261
4. B. Chaudhari, R. Asija, S. Asija, C.J. Patel, P. Patel, and J. Patel Comparative study between inclusion complex with hydroxypropyl-β-cyclodextrin and nanocrystal technology for enhancement of solubility and dissolution rate of poorly soluble drug albendazole J. Drug Discov. Ther. 1 2013 05 14
5. A. Chaudhary, U. Nagaich, N. Gulati, V.K. Sharma, and R.L. Khosa Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: a recent review J. Adv. Pharm. Educ. Res. 2 2012 32 67
6. W.S. Cheow, and K. Hadinoto Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility J. Colloid Interface Sci. 367 2012 518 526
7. 25-35 in mice J. Asian Nat. Prod. Res. 11 2009 1019 1027
8. T.Y. Chi, L.H. Wang, X.F. Ji, L. Shen, and L.B. Zou Protective effect of xanthoceraside against β-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells J. Asian Nat. Prod. Res. 15 2013 1013 1022
9. E.E. Connor, J. Mwamuka, A. Gole, C.J. Murphy, and M.D. Wyatt Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity Small 1 2005 325 327
10. N.S. Elbialy, M.M. Fathy, and W.M. Khalil Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery Int. J. Pharm. 490 2015 190 199
11. A. Geçer, N. Yildiz, and A. Çalimli Trimethyl chitosan nanoparticles enhances dissolution of the poorly water soluble drug candesartan-cilexetil Macromol. Res. 18 2010 986 991
12. K. Gokuladhas, S. Jayakumar, A. Madankumar, B. Rajan, R. Elamaran, S. Pramila, and T. Devaki Synthesis and characterization of biocompatible gold nanoparticles stabilized with hydrophilic polymer coated hesperetin drug for sustained drug delivery to treat hepatocellular carcinoma-derived cancer cells J. Pharm. Res. 8 2014 98 105
13. Jung Y. Hahr Physiology of the Alzheimer's disease Med. Hypotheses 85 2015 944 946
14. B.C. Hancock, and M. Parks What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17 2000 397 404
15. K. Hemant, P.R. Daima, R. Selvakannan Shukla, K. Suresh, and V. Bhargava Bansal Fine-tuning the antimicrobial profile of biocompatible gold nanoparticles by sequential surface functionalization using polyoxometalates and lysine PLoS One 8 2013 1 14
16. G. Jin, L.H. Wang, X.F. Ji, T.Y. Chi, Y. Qi, Q. Jiao, Q. Xu, X.Y. Zhou, R. Zhang, and L.B. Zou Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice Neurosci. Lett. 573 2014 58 63
17. R.X. Jin, Y. Yang, Y.C. Zou, X.C. Liu, and Y. Xing A general route to hollow mesoporous rare-earth silicate nanospheres as a catalyst support Chem. Eur. J. 20 2014 2344 2351
18. H. Kansara, R. Panola, and A. Mishra Techniques used to enhance bioavailability of BCS class II drugs: a review Int. J. Drug Dev. Res. 7 2015 82 93
19. D. Kim, Y. Jeong, C. Choi, S. Roh, S. Kang, M. Jang, and J. Nah Retinol-encapsulated low molecular water-soluble chitosan nanoparticles Int. J. Pharm. 319 2006 130 138
20. Y. Kobayashi, Y. Tadaki, D. Nagao, and M. Konno Deposition of gold nanoparticles on silica spheres by electroless metal plating technique J. Colloid Interface Sci. 283 2005 601 604
21. D. Law, E.A. Schmitt, K.C. Marsh, E.A. Everitt, W.L. Wang, J.J. Fort, S.L. Krill, and Y.H. Qiu Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations J. Pharm. Sci. 93 2004 563 570
22. C. Lin, F. Chen, T.T. Ye, L. Zhang, W.J. Zhang, D.D. Liu, W. Xiong, X.G. Yang, and W.S. Pan A novel oral delivery system consisting in drug-in cyclodextrin-in nanostructured lipid carriers for poorly water-soluble drug: vinpocetine Int. J. Pharm. 465 2014 90 96
23. J.H. Ling, L.L. Liu, Y.X. Wang, Z.Y. Li, R. Liu, Q. Li, Y. Wang, B.Z. Yang, X.H. Chen, and K.S. Bi Characterization and quantification of the triterpenoids in different parts of Xanthoceras sorbifolia by HPLC-ESI-MS J. Pharm. Biomed. 55 2011 259 264
24. P. Liu, L.B. Zou, L.H. Wang, Q. Jiao, T.Y. Chi, X.F. Ji, and G. Jin Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats Psychopharmacology 231 2014 345 356
25. Z.J. Liu, F. Zhang, G.Y. Koh, X. Dong, J. Hollingsworth, J. Zhang, P.S. Russo, P.Y. Yang, and R.W. Stout Cytotoxic and antiangiogenic paclitaxel solubilized and permeation-enhanced by natural product nanoparticles Anti-Cancer Drug 26 2015 167 179
26. P. Liua, L. Zoua, Q. Jiao, T.Y. Chi, X.F. Ji, Y. Qi, Q. Xu, and L.H. Wang Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats Neurosci. Lett. 543 2013 115 120
27. P. Lu, T. Mamiya, L.L. Lu, A. Mouri, T. Ikejima, H.C. Kim, L.B. Zou, and T. Nabeshima Toshitaka Nabeshima: xanthoceraside attenuates amyloid β peptide-induced learning and memory impairments in mice Psychopharmacology 219 2012 181 190
28. A. Mohan, M. Madhavi, and P. Jyosthna Preparation in vitro and in vivo characterization of solid dispersions of oxcarbazepine using melting technique J. Pharm. Innov. 3 2015 99 103
29. T.B. Patel, and L.D. Patel Formulation and development strategies for drugs insoluble in gastric fluid Int. Res. J. Pharm. 3 2012 106 113
30. M. Shah, Z. Farooqui, J. Shah, N. Shah, and S. Sheorey Solid dispersion - a way to enhance solubility of quetiapine fumarate Am. J. PharmTech Res. 3 2013 732 748
31. R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R.R. Bhonde, and M. Sastry Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview Langmuir 21 2005 10644 10654
32. Y. Sun, L. Zhu, T. Wu, T. Cai, E.M. Gunn, and L. Yu Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additives AAPS 14 2012 380 388
33. J.M. Tam, J.T. McConville, R.O. Williams, and K.P. Johnston Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution J. Pharm. Sci. 97 2008 4915 4933
34. Y.Y. Tu, X.X. Xu, and F. Qiu Research progress in the prodrugs of curcumin Chin. J. Org. Chem. 32 2012 852 859
35. V. Venkatpurwar, A. Shiras, and V. Pokharkar Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: in vitro cytotoxicity study Int. J. Pharm. 409 2011 314 320
36. Y.Q. Wang, K.L. Shi, Z.X. Liao, L.J. Ji, and H.F. Sun Improving dissolution of antihepatitis-effective-ingredients total xanth-one glucosides of Halenia elliptica J. Southeast Univ. 41 2011 809 814
37. X. Wang, Q. Zhu, D.L. Meng, L.H. Wang, and Y. Wang Process research of separation and purification of xanthoceraside by macroporous resin J. Shenyang Pharm. Univ. 29 2012 147 151
38. W. Yang, K.P. Johnston, and R.O. Williams Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats Eur. J. Pharm. Biopharm. 75 2010 33 41
39. J. Yang, H.W. Shen, X. Zhang, Y.Y. Tao, H. Xiang, and G.M. Xie A novel platform for high sensitivity determination of PbP2a based on gold nanoparticles composited graphitized mesoporous carbon and doxorubicin loaded hollow gold nanospheres Biosens. Bioelectron. 77 2016 1119 1125
40. Z.Q. Zhou, Y.Q. Cai, X.F. Zhang, B.Y. Li, and S.S. Zhu Analysis on low transfer rate of active constituents by water extracting from Chinese materia medica Chin. Tradit. Herb. Drugs 45 2014 3478 3485